Elafibranor
Tier C — Watch / tradeElafibranor
Targets：PPARα, PPARδ
Brand：Iqirvo
Indications (approved)：Sclerosing cholangitis, Biliary cirrhosis
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| ELAF-001 | 1778-09-2 | 1-(4-(methylthio)phenyl)ethan-1-one |
| ELAF-002 | 2233-18-3 | 4-hydroxy-3,5-dimethylbenzaldehyde |
| ELAF-003 | 824932-89-0 | (E)-3-(4-hydroxy-3,5-dimethylphenyl)-1-(4-(methylthio)phenyl)prop-2-en-1-one |
| ELAF-004 | 51368-55-9 | isopropyl 2-bromo-2-methylpropanoate |
| ELAF-005 | 1000335-03-4 | isopropyl (E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoate |
Frequently asked questions
What are the approved indications of Elafibranor?
Approved indications include: Sclerosing cholangitis, Biliary cirrhosis.
When does the Elafibranor patent expire?
No public expiry year is available for Elafibranor yet; this page updates once verified.
How many synthesis routes are recorded for Elafibranor?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Elafibranor intermediates?
All intermediates in Elafibranor routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Elafibranor intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29